New partnerships with national Complex Rehab Technology (CRT) and prosthetics/orthotics providers are expected to grow Ekso Bionics’ Personal Health Products segment for 2025, the company announced during its May 5 earnings call. Ekso Bionics (Nasdaq: EKSO) reported earnings results for the three months ending on March 31, 2025, while also commenting on what the company…
Ekso Bionics Q1 Earnings: Partnerships with NSM, Bionic P&O Expected to Grow Personal Health Products Segment This Year
Ekso Bionics to Focus on Indego Personal Exoskeleton Expansion Through CRT, DME Channels
The company shared its plans during a March 3 earnings call.
In an earnings call covering its 2024 full-year results, executives from Ekso Bionics (Nasdaq: EKSO) described the company’s plans to get its Ekso Indego Personal exoskeleton into the hands of more patients. “Revenue of $17.9 million was down from $18.3 million for the same period in 2023,” Ekso Bionics CFO Jerome Wong said, in describing…